Now in its fourth year SLF 2025 explores the key funding factors specialty lenders should consider from launch phase to maturity, and eventual exit via M&A or a public ABS deal. Investors will have a unique forum to meet emerging and established non-bank financial institutions originating a variety of financial assets and participate in a sector with an attractive yield and risk profile. Funds seeking to expand their lending activities beyond corporate direct lending will be able to showcase their platforms to an audience of potential borrowers and allocators alike.

A Sampling of Allocators Confirmed to Attend

Aksai | Albourne Partners | Aon | Aviva Insurance | British Business Bank | CDPQ | CPP Investments | Dai-ichi Life | Haringey local government pension fund | Hyman Roberts | Legal & General | London CIV | MetLife | Nest Pension | Pension Insurance Corporation | Phoenix Group | Railpen | Scottish Widows | Sumitomo Life Insurance | USS | Vienna Insurance Group | XPS Group

A Sampling of Borrowers Confirmed to Attend

Amplifi Capital | April Mortgages | Claro | Equifinance | Funding 365 | Funding Circle | Keystone Properties Finance | Lendhub | LendingCrowd | LendInvest | Lendwise | Masthaven Finance | Molo Finance | Norton Home Loans | Pepper Money | Rent2Cash | Spring Finance | Together Money | Ultimate Finance Group

WHO SHOULD ATTEND

WHAT ATTENDEES SAID ABOUT SLF 2024

"If you are operating in the specialty finance space at all, you owe it to yourself to attend the Dealcatalyst asset-based series of conferences. They are extremely worthwhile with just the right focus and are just the right size."

Gary Miller

Director, Speciality Finance

Revere Capital

"A great opportunity to meet serious, well informed peers looking to do business. Networking was easy and effective via the app and facilities on the day were excellent. All round very professional, a worthwhile ay."

Brian Rubins

Director

Alternative Bridging Corporation Limited